- Issuer ticker
-
JAZZ
- Reported as of
-
06 Aug 2021
- Net transaction value
-
-$209,215
- SEC form
-
4
- Accepted by SEC
-
10 Aug 2021, 17:34:22 UTC
Filing notes and source
Key filing fact
Peter Gray filed Form 4 for Jazz Pharmaceuticals plc (JAZZ) on 10 Aug 2021.
Key facts
- This page summarizes Peter Gray's Form 4 filing for Jazz Pharmaceuticals plc (JAZZ).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 10 Aug 2021, 17:34.
Change
- Previous filing in this sequence was filed on 02 Aug 2021.
- Current net transaction value: -$209,215.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
JAZZ
transaction
Ordinary Shares
Sale
- Transaction value
- -$209,215
- Shares
- -1,414
- Change %
- -9.9%
- Price
-
$147.96
- Shares after
- 12,852
- Date
- 06 Aug 2021
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote